Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Spasticity and autonomic dysreflexia

Neurology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

In a person with spinal injury at or above T6, a sudden pounding headache, flushing or sweating with a systolic blood-pressure rise of 20 mmHg or more above their usual level suggests autonomic dysreflexia. Sit upright, lower the legs, loosen clothing, monitor pressure every 2–5 minutes and remove bladder or bowel triggers urgently; call emergency help if unresolved.

Synopsis

Manage spasticity by function and triggers, preserve useful tone and recognise autonomic dysreflexia after high spinal injury as a hypertensive emergency requiring immediate trigger removal.

  • Spasticity is a velocity-dependent increase in stretch reflex tone after upper-motor-neurone injury; spasms, clonus, stiffness, dystonia, rigidity and fixed contracture are related but not interchangeable findings.
  • Tone can help standing, transfers, venous return or continence, so treatment targets pain, sleep, hygiene, skin, gait or care goals rather than a normal tone score.
  • A sudden increase usually signals a trigger below the neurological level: urinary infection or retention, catheter blockage, constipation, pressure injury, fracture, ingrown nail, tight equipment or pain.
  • Positioning, stretching, splinting, standing, task practice and equipment review are the foundation, delivered by rehabilitation teams after triggers and biomechanics are assessed.
  • For generalised spasticity in MS, NICE recommends oral baclofen first line when goals are improved mobility, pain or spasms; titrate slowly to benefit because weakness can worsen function.
  • Botulinum toxin treats selected focal overactivity, while intrathecal baclofen is considered for severe generalised disease after a successful specialist test and support plan.
  • Abrupt baclofen withdrawal can cause rebound spasticity, fever, confusion, autonomic instability, rhabdomyolysis and seizures, particularly after pump failure.
  • Autonomic dysreflexia is uncontrolled sympathetic discharge below a usually T6-or-higher lesion after spinal shock, most often triggered by bladder distension or a blocked catheter.
  • The person's baseline blood pressure may be low, so a dangerous rise can still appear normal to an unfamiliar observer; compare with their usual value and symptoms.
  • After sitting upright, examine the catheter and bladder first, then bowel, skin and other triggers; use short-acting antihypertensive treatment under the emergency plan if pressure remains dangerously elevated.

Key red flags

Trigger-driven deterioration

Previously stable tone suddenly increases with urinary symptoms, blocked catheter, constipation, pressure damage, fracture, tight splint, menstruation or another painful stimulus.

Autonomic dysreflexia

A high cord-injured person develops sudden hypertension above baseline, pounding headache, facial flushing, sweating or nasal blockage, sometimes with bradycardia and cool piloerect skin below.

Bladder trigger

A kinked, blocked or overfull catheter bag, retention, instrumentation or urinary infection precedes the episode; bladder distension is the commonest cause and is checked first.

Baclofen withdrawal

Abrupt oral cessation or pump interruption causes rapidly escalating generalised tone, pruritus, fever, agitation, hallucination, autonomic instability or seizures and can mimic sepsis.

Investigation priorities

01
Goal-based tone and function assessmentFirst step

Separate neural spasticity from contracture and determine which activity, comfort or care outcome treatment should change.

Management branches

Spasticity reviewTreat trigger, then tone

Tone, spasms or clonus becomes painful, functionally limiting or suddenly worse.

  1. Define one or more measurable goals and establish whether current tone helps posture or transfer, while distinguishing dynamic spasticity from fixed shortening or dystonia.
  2. Search systematically for bladder, bowel, skin, infection, fracture, pain and equipment triggers and correct these before escalating long-term antispastic treatment.
  3. Optimise positioning, stretching, orthoses, standing and task practice, then introduce low-dose baclofen or a focal intervention through rehabilitation or neurology review.
  4. Reassess goal and adverse weakness after each change and refer complex generalised disease for toxin, intrathecal or multidisciplinary options.

Key medicines

Oral baclofenA common adult start is 5 mg three times daily, increased gradually to the lowest effective dose.Sedation, weakness, dizziness and respiratory risk can impair transfers and falls; reduce for renal impairment and never stop sustained treatment abruptly.
TizanidineBegin at a low specialist-selected dose and titrate slowly according to daytime and nocturnal goals.Hypotension, sedation, dry mouth, liver injury and major CYP1A2 interactions occur; monitor liver function under product and local guidance.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Royal National Orthopaedic Hospital autonomic dysreflexia
  • Spinal Injuries Association dysreflexia factsheet
  • NICE NG220 multiple sclerosis spasticity recommendations
  • NICE BNF baclofen monograph

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom